Skip to content
EU Startups News
  • Funding
  • Launch
  • Partnership
  • Acquisition
  • Policy
  • Exit & IPO

Boltz

Nvidia Backs UK AI Drug Discovery Startup Boltz in Five-Company Investment Push

October 15, 2026 by James O'Brien

Nvidia said it is taking minority stakes in five UK startups – Boltz, Foresight, Hiverge, Prima Mente and Riverlane – to deepen its presence in the European AI ecosystem. Boltz, an AI‑driven drug discovery company, is one of the beneficiaries of this new investment round.

Categories Funding Tags Boltz, Healthtech, United Kingdom Leave a comment
Browse by Country

Latest

Leonard Punt Appointed General Director of Dutch AI-Focused Digital Studio Q42Oct 15, 2026
Finnish Startup Ambio Secures €5.1M Seed Round to Scale AI-Powered Recycled Plastics MarketplaceOct 15, 2026
Romanian E-Commerce Retailer evomag Invests 200,000 EUR in Platform Upgrade Ahead of Black Friday 2026Oct 15, 2026
Skeleton Technologies Joins European Unicorn Club with Siemens Backing and US Expansion PlansOct 15, 2026
Nvidia Backs UK AI Drug Discovery Startup Boltz in Five-Company Investment PushOct 15, 2026

EU Markets

European Markets Flash Warning Signs and Green Lights for Startups This WeekOct 9, 2026
European Fintech Expands, Crypto Matures, and Capital Shifts: What This Week's Financial News Means for StartupsOct 2, 2026
European Financial Markets Weekly: Billion-Dollar Raises, Banking Stress Tests, and What It All Means for Your StartupSep 25, 2026
Europe's Financial Markets Are Shifting — Here's What Startup Founders Need to Know This WeekSep 18, 2026

EU Startups News
• About Us • Privacy Policy

Follow Us

LinkedIn X / Twitter Facebook

Stay informed

Get the latest European startup news delivered to your inbox every week. For broader markets news, visit: EU Finance News

No spam. Unsubscribe anytime.

By continuing to use this site you agree to our Privacy Policy and the use of cookies.

© 2026 EU Startups News • Built with GeneratePress

By continuing to use this site you agree to our Privacy Policy and the use of cookies.